SALT LAKE CITY, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and financial results for its fourth quarter and fiscal year ended December 31, 2024.
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Seeking Alpha / 5 minutes ago 2 Views
Comments